WallStreetZenWallStreetZen

Sectors & IndustriesConsumer DefensivePharmaceutical Retailers
Best Pharmaceutical Retailer Stocks to Buy Now (2024)
Top pharmaceutical retailer stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

Industry: Pharmaceutical Retailers
Ticker
Company
Zen Score
Valuation Score
Financials Score
Forecast Score
Performance Score
Dividends Score
PETS
PETMED EXPRESS INC
26
43
57
11
20
0
HITI
HIGH TIDE INC
25
0
57
11
30
CJJD
CHINA JO-JO DRUGSTORES INC
20
14
57
0
10
SSY
SUNLINK HEALTH SYSTEMS INC
20
14
57
0
10
YI
111 INC
19
0
57
0
20

Upgrade to Premium to View More

Use Zen Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail.

Already have a premium account? Sign In

Pharmaceutical Retailer Stocks FAQ

What are the best pharmaceutical retailer stocks to buy right now in May 2024?

According to Zen Score, the 3 best drug store stocks to buy right now are:

1. Petmed Express (NASDAQ:PETS)


Petmed Express (NASDAQ:PETS) is the top pharmaceutical retailer stock with a Zen Score of 26, which is 7 points higher than the pharmaceutical retailer industry average of 19. It passed 10 out of 38 due diligence checks and has average fundamentals. Petmed Express has seen its stock lose -74.05% over the past year, underperforming other pharmaceutical retailer stocks by -19 percentage points.

Petmed Express has an average 1 year price target of $6.50, an upside of 64.56% from Petmed Express's current stock price of $3.95.

Petmed Express stock has a consensus Strong Sell recommendation according to Wall Street analysts. Of the 1 analyst covering Petmed Express, 0% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 100% have issued a Strong Sell.

2. High Tide (NASDAQ:HITI)


High Tide (NASDAQ:HITI) is the second best pharmaceutical retailer stock with a Zen Score of 25, which is 6 points higher than the pharmaceutical retailer industry average of 19. It passed 8 out of 33 due diligence checks and has weak fundamentals. High Tide has seen its stock return 76.15% over the past year, overperforming other pharmaceutical retailer stocks by 131 percentage points.

High Tide has an average 1 year price target of $4.50, an upside of 96.51% from High Tide's current stock price of $2.29.

High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Sunlink Health Systems (NYSEMKT:SSY)


Sunlink Health Systems (NYSEMKT:SSY) is the third best pharmaceutical retailer stock with a Zen Score of 20, which is 1 points higher than the pharmaceutical retailer industry average of 19. It passed 6 out of 33 due diligence checks and has weak fundamentals. Sunlink Health Systems has seen its stock lose -41.07% over the past year, overperforming other pharmaceutical retailer stocks by 14 percentage points.

What are the pharmaceutical retailer stocks with highest dividends?

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

1. Trxade Health (NASDAQ:MEDS)


Trxade Health (NASDAQ:MEDS) has an annual dividend yield of 134.23%, which is 81 percentage points higher than the pharmaceutical retailer industry average of 52.98%.

Trxade Health's dividend payout ratio of -34.2% indicates that its high dividend yield might not be sustainable for the long-term.

2. Walgreens Boots Alliance (NASDAQ:WBA)


Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 9.53%, which is -43 percentage points lower than the pharmaceutical retailer industry average of 52.98%. Walgreens Boots Alliance's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Walgreens Boots Alliance's dividend has not shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -24.1% indicates that its high dividend yield might not be sustainable for the long-term.

Why are pharmaceutical retailer stocks up?

Pharmaceutical retailer stocks were up 1.22% in the last day, and down -1.87% over the last week. Leafly Holdings was the among the top gainers in the pharmaceutical retailers industry, gaining 51.43% yesterday.

Shares of cannabis stocks are trading higher following a report indicating the DEA is moving to reclassify marijuana as a less dangerous drug.

What are the most undervalued pharmaceutical retailer stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

1. Petmed Express (NASDAQ:PETS)


Petmed Express (NASDAQ:PETS) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Petmed Express has a valuation score of 43, which is 34 points higher than the pharmaceutical retailer industry average of 9. It passed 3 out of 7 valuation due diligence checks.

Petmed Express's stock has dropped -74.05% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -19 percentage points.

2. Walgreens Boots Alliance (NASDAQ:WBA)


Walgreens Boots Alliance (NASDAQ:WBA) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Walgreens Boots Alliance has a valuation score of 14, which is 5 points higher than the pharmaceutical retailer industry average of 9. It passed 1 out of 7 valuation due diligence checks.

Walgreens Boots Alliance's stock has dropped -48.77% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 6 percentage points.

3. Sunlink Health Systems (NYSEMKT:SSY)


Sunlink Health Systems (NYSEMKT:SSY) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Sunlink Health Systems has a valuation score of 14, which is 5 points higher than the pharmaceutical retailer industry average of 9. It passed 1 out of 7 valuation due diligence checks.

Sunlink Health Systems's stock has dropped -41.07% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 14 percentage points.

Are pharmaceutical retailer stocks a good buy now?

50% of pharmaceutical retailer stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical retailer stocks to rise by 49.96% over the next year.

What is the average p/e ratio of the pharmaceutical retailers industry?

The average P/E ratio of the pharmaceutical retailers industry is -2.69x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.